JNK and p38 are activated by erythropoietin (EPO) but are not induced in apoptosis following EPO withdrawal in EPO-dependent HCD57 cells

Blood

Volumn 96, Issue 3, 2000, Pages 933-940

  Jacobs Helber, S M ^a   Ryan, J J ^a   Sawyer, S T ^a  

^a Dept of Pharmacology/Toxicology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROPOIETIN; GROWTH FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INDUCTION; ERYTHROID CELL; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034254515     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.3.933     Document Type: Article

References (58)

1. The molecular mechanism of erythropoietin action
2. Erythropoietin
3. Erythropoietin cell biology
4. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor
5. ERKs a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF
6. The MAPK signaling cascade
7. Regulation and function of the JNK subgroup of MAP kinases
8. From receptors to stress-activated MAP kinases
9. Components of a new human protein kinase signal transduction pathway
10. Stress-activated protein kinases: Activation, regulation and function
11. 2-terminal kinase regulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation
12. Dexa-methasone induces apoptosis of multiple myeloma cells in a JNK/SAP kinase independent mechanism
13. Withdrawal of survival factors results in activation of the JNK pathway in neuronal cells leading to Fas ligand induction and cell death
14. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
15. Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-α in rat mesangial cells
16. Pro-inflammatory cytokines stimulate mitogen-activated protein kinase subfamilies, increase phosphorylation of c-Jun and ATF2 and upregulate c-Jun protein in neonatal rat ventricular myocytes
17. The role of p38 mitogen-activated protein kinase in IL-6 and IL-8 production from the TNF-alpha- or IL-1beta-stimulated rheumatoid synovial fibroblasts
18. Activation of the stress-activated protein kinases by multiple hematopoietic growth factors with the exception of interleukin-4
19. Kit signaling through PI 3-kinase and Src kinase pathways: An essential role for Rac1 and JNK activation in mast cell proliferation
20. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3
21. Interleukin-4 synergizes with Raf-1 to promote long-term proliferation and activation of c-jun N-terminal kinase
22. TRAF2 is essential for JNK but not NF-kappaB activation and regulates lymphocyte proliferation and survival
23. The TNF receptor family member CD27 signals to Jun N-terminal kinase via Traf-2
24. Implication of TNF receptor-I-mediated extra-cellular signal-regulated kinases 1 and 2 (ERK1/2) activation in growth of AIDS-associated Kaposi's sarcoma cells: A possible role of a novel death domain protein MADD in TNF- alpha-induced ERK1/2 activation in Kaposi's sarcoma cells
25. Tumor necrosis factor alpha is an autocrine growth regulator during macrophage differentiation
26. Signal transduction during liver regeneration
27. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
28. p38 MAPK signaling cascades in inflammatory disease
29. Encounters with Fos and Jun on the road to AP-1
30. Oncogene jun encodes a sequence-specific trans-activator similar to AP-1
31. Jun-D: A third member of the Jun family
32. Characterization of Jun D: A new member of the jun oncogene family
33. Phorbol ester-induced amino-terminal phosphorylation of human JUN but not JUNB regulates transcriptional activation
34. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions
35. Inducible and constitutive transcription factors in the mammalian nervous system: Control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins
36. Activation of p90RSK and cAMP response element binding protein in stimulated neutrophils: Novel effects of the pyridinyl imidazole SB 203580 on activation of the extracellular signal-regulated kinase cascade
37. RSK-B, a novel ribosomal S6 kinase family member, is a CREB kinase under dominant control of p38alpha mitogen-activated protein kinase (p38alphaMAPK)
38. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3
39. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation
40. Requirement of activation of JNK and p38 for environmental stress- induced erythroid differentiation and apoptosis and of inhibition of ERK for apoptosis
41. AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells
42. Distinct roles of JNKs/p38 MAP kinase and ERKs in apoptosis and survival of HCD-57 cells induced by withdrawal or addition of erythropoietin
43. Erythropoietin-dependent and erythropoietin-producing cell lines: Implications for research and for leukemia therapy
44. Friend spleen focus-forming virus induces factor independence in an erythropoietin-dependent erythroleukemia cell line
45. The functional form of the erythropoietin receptor is a 78-kDa protein: Correlation with cell surface expression, endocytosis, and phosphorylation
46. Erythropoietin induces the tyrosine phosphorylation nuclear translocation and DNA binding of STAT1 and STAT5 in erythroid cells
47. Distinct signaling from stem cell factor and erythropoietin in HCD57 cells
48. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: A mechanism for controlled rates of erythrocyte production
49. Phosphatidylinositol 3-kinase mediates epidermal growth factor-induced activation of the c-Jun N-terminal kinase signaling pathway
50. Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF
51. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI Cells)
52. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor
53. Induction of apoptosis signal regulating kinase 1 (ASK1) after spinal cord injury in rats: Possible involvement of ASK1-JNK and -p38 pathways in neuronal apoptosis
54. Repetitive electroconvulsive seizures induce activity of c-Jun N- terminal kinase and compartment-specific desensitization of c-Jun phosphorylation in the rat brain
55. The subcellular locations of p15(Ink4b) and p27(Kip1) coordinate their inhibitory interactions with cdk4 and cdk2
56. Activation of the mitogen-activated protein kinase pathway by the erythropoietin receptor
57. Inhibition by dexamethasone of antigen-induced c-Jun N-terminal kinase activation in rat basophilic leukemia cells
58. Multiple signaling pathways for the activation of JNK in mast cells: Involvement of Bruton's tyrosine kinase, protein kinase C, and JNK kinases, SEK1 and MKK7